Stocks

The table gives an overview of all stocks, alphabetically sorted.
 O-I Glass, Inc. OI Mar 1, 2021 12.06 +3.25   
 O2Micro International Limited - American Depositary Shares OIIM Mar 1, 2021 8.00 +3.23   
 Oak Street Health Inc OSH Mar 1, 2021 51.97 -2.00   
 Oak Valley Bancorp (CA) OVLY Mar 1, 2021 17.13 +6.00   
 Oaktree Acquisition Corp II OACB Mar 1, 2021 10.43 -1.04   
 Oaktree Capital Group LLC 6.55% PRF PERPETUAL USD 25 - Ser B OAK-B Mar 1, 2021 26.25 +1.67   
 Oaktree Capital Group LLC 6.625% PRF PERPETUAL USD 25 - Ser OAK-A Mar 1, 2021 26.35 +0.65   
 Oaktree Specialty Lending Corporation OCSL Mar 1, 2021 6.19 +0.65   
 Oaktree Strategic Income Corporation OCSI Mar 1, 2021 8.36 +0.97   
 Oasis Midstream Partners LP - Common Units, Representing Lim OMP Mar 1, 2021 19.97 +4.28   
 Oasis Petroleum Inc. OAS Mar 1, 2021 58.00 0.00   
 Obalon Therapeutics, Inc. OBLN Mar 1, 2021 3.62 +5.54   
 Oblong Inc. OBLG Mar 1, 2021 4.46 +8.52   
 ObsEva SA - OBSV Mar 1, 2021 3.85 -1.28   
 OCA Acquisition Corp. - Unit OCAXU Mar 1, 2021 10.30 0.00   
 Occidental Petroleum Corporation OXY Mar 1, 2021 27.64 +3.87   
 Ocean Bio-Chem, Inc. OBCI Mar 1, 2021 11.33 +8.42   
 Ocean Power Technologies, Inc. OPTT Mar 1, 2021 3.88 +5.59   
 Oceaneering International, Inc. OII Mar 1, 2021 12.83 +8.73   
 OceanFirst Financial Corp. OCFC Mar 1, 2021 22.60 +4.00   
 OceanFirst Financial Corp. - Depositary Shares OCFCP Mar 1, 2021 27.35 +0.48   
 Oconee Federal Financial Corp. OFED Mar 1, 2021 25.99 +3.96   
 Ocugen, Inc. OCGN Mar 1, 2021 10.02 -8.49   
 Ocular Therapeutix, Inc. OCUL Mar 1, 2021 19.46 +6.11   
 Ocuphire Pharma, Inc. OCUP Mar 1, 2021 10.53 -0.75   
 Ocwen Financial Corporation NEW OCN Mar 1, 2021 28.00 +0.11   
 Odonate Therapeutics, Inc. ODT Mar 1, 2021 19.35 -8.08   
 Odyssey Marine Exploration, Inc. OMEX Mar 1, 2021 7.32 +1.39   
 Office Properties Income Trust - OPI Mar 1, 2021 26.04 +2.97   
 OFG Bancorp OFG Mar 1, 2021 20.07 +3.94   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK